(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 4.15% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.36%.
Rxsight's revenue in 2026 is $134,479,000.On average, 14 Wall Street analysts forecast RXST's revenue for 2026 to be $5,540,830,800, with the lowest RXST revenue forecast at $5,176,449,062, and the highest RXST revenue forecast at $6,290,227,444. On average, 13 Wall Street analysts forecast RXST's revenue for 2027 to be $6,022,408,930, with the lowest RXST revenue forecast at $5,301,898,721, and the highest RXST revenue forecast at $6,881,574,025.
In 2028, RXST is forecast to generate $6,492,019,822 in revenue, with the lowest revenue forecast at $5,783,064,187 and the highest revenue forecast at $7,084,604,393.